MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-WB-14-0011670
Jibok Pharmaceuticals Private Limited - pharma in Kolkata, West Bengal, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.46 Cr
Latest filing
Net profit · FY 2025
₹3.63 Lakh
Net margin 2.5%
EBITDA · FY 2025
₹6.53 Lakh
EBITDA margin 4.5%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹15 Lakh
Issued & subscribed
Open charges
₹40.04 Lakh
Secured borrowings
Company age
19 yrs
Est. 2007
Employees · EPFO
20
Provident fund records
About Jibok Pharmaceuticals Private Limited
Data last updated:
Jibok Pharmaceuticals Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 12 October 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24232WB2007PTC119509. Its GSTIN is 19AABCJ9104C1ZU (West Bengal).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors including Tushar Kanti Ghosh and Pradip Kumar Ghosh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 26(5/4) Barasat Road P.O – Nona – Chandanpukur P.S. Titagarh Muncipality – Barrackpore, Kolkata, West Bengal, India – 700122.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.46 Cr. For the same year it recorded a net profit of ₹3.63 Lakh (net margin 2.5%) and EBITDA of ₹6.53 Lakh (EBITDA margin 4.5%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 11% over five years.
The company has about 20 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹40.04 Lakh on record.
Jibok Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-14-0011670). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website jibokpharmaceuticals.com.
Company details
CIN U24232WB2007PTC119509
Registration Number 119509
Incorporation Date 12 October 2007
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-WB-14-0011670
Recognitions & Rankings of Jibok Pharmaceuticals
Contact details
Jibok Pharmaceuticals Private Limited's registered office is in Kolkata, West Bengal. Its website is jibokpharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address26(5/4) Barasat Road P.O – Nona – Chandanpukur P.S. Titagarh Muncipality – Barrackpore, Kolkata, West Bengal, India – 700122
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Jibok Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Jibok Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Jibok Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Jibok Pharmaceuticals Private Limited, buy the company report.
Financials of Jibok Pharmaceuticals Private Limited
FY 2025 filings availableJibok Pharmaceuticals Private Limited reported revenue of ₹1.46 Cr for FY 2025.
Revenue · FY 2025
₹1.46 Cr
Net profit · FY 2025
₹3.63 Lakh margin 2.5%
EBITDA · FY 2025
₹6.53 Lakh margin 4.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
3 years · compounded
▲ 16%
5 years · compounded
▲ 11%
EBITDA CAGR growth
1 year
▲ 10%
3 years · compounded
▲ 18%
5 years · compounded
▲ 13%
Revenue has grown at a compounded annual rate (CAGR) of 11% over five years. EBITDA rose 10% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.53 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.63 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.5% | ||||
| Net Profit Margin | 2.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Jibok Pharmaceuticals Private Limited, buy the company report.
Board of directors of Jibok Pharmaceuticals Private Limited
Jibok Pharmaceuticals has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tushar Kanti Ghosh Also directs: Jimbiosis Healthcare Private Limited | Director | 12 Oct 2007 | 19 Years 0 Months | Current |
| Pradip Kumar Ghosh | Director | 12 Oct 2007 | 19 Years 0 Months | Current |
| Satyajit Acharjee Also directs: Jimbiosis Healthcare Private Limited | Director | 12 Oct 2007 | 19 Years 0 Months | Current |
| Rajesh Kumar Sah | Director | 12 Oct 2007 | 19 Years 0 Months | Current |
Peer comparison
Jibok Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Indo Fusion Interiors Private Limited | ₹1.46 Cr (FY 2024) | 40.0% | Delhi, India | |||
| Azeudus Pharmaceuticals Private Limited | ₹1.46 Cr (FY 2022) | 128.0% | Bangalore, Karnataka, India | |||
| Jibok Pharmaceuticals Private Limitedthis company | ₹1.46 Cr (FY 2025) | ₹3.63 Lakh | 2.5% | 20 | Kolkata, West Bengal, India | |
| Assurmed Pharmacy Private Limited | ₹1.45 Cr (FY 2023) | 2028.0% | Delhi, India |
To see the full peer comparison of Jibok Pharmaceuticals Private Limited, buy the company report.
Auditor
Jibok Pharmaceuticals Private Limited is audited by PRADEEP S GOEL & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PRADEEP S GOEL & CO. | FY 2017 | 325255E |
Shareholding
The shareholding of Jibok Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Jibok Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹40.04 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Apr 2018 | 100174545 | Bank of India | ₹40.04 Lakh | Open |
To see the full charge records of Jibok Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Jibok Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Jibok Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Jibok Pharmaceuticals Private Limited has a workforce of 20 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Employee count
20
Active EPFO establishments
1
Employee growth
5.3%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 20 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Jibok Pharmaceuticals Private Limited, buy the company report.
GST
Jibok Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AABCJ9104C1ZU | West Bengal | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Jibok Pharmaceuticals Private Limited, buy the company report.
Recent activity
Jibok Pharmaceuticals Private Limited has 5 board changes on record since 2007: 4 appointments and 1 cessation. The latest: Biplab Raychaudhuri ceased to be Director on 11 Aug 2012.
AGM
Jibok Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Jibok Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata.
Charges
A charge with Bank Of India of Rs. 40.04 Lakh registered on 17 Apr 2018 with Charge ID 100174545 was modified on 24 May 2023.
Charges
A charge with Bank Of India amounted to Rs. 40.04 Lakh with Charge ID 100174545 was registered on 17 Apr 2018.
Ceased
Biplab Raychaudhuri ceased to be Director.
Appointed
Pradip Kumar Ghosh was appointed as Director.
Appointed
Rajesh Kumar Sah was appointed as Director.
Appointed
Satyajit Acharjee was appointed as Director.
Appointed
Tushar Kanti Ghosh was appointed as Director.
Incorporation
12 Oct 2007
Jibok Pharmaceuticals Private Limited was registered on 12 Oct 2007 with Roc Kolkata & aged 19 years 1 month as per MCA records.
Frequently asked questions
Jibok Pharmaceuticals is an active private limited company based in Kolkata, West Bengal, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 12 October 2007 (19+ years old) and is registered under CIN U24232WB2007PTC119509.
Jibok Pharmaceuticals has 4 current directors:
- Tushar Kanti Ghosh - Director
- Pradip Kumar Ghosh - Director
- Satyajit Acharjee - Director
- Rajesh Kumar Sah - Director
The latest financial statements of Jibok Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Jibok Pharmaceuticals is 19AABCJ9104C1ZU, registered in West Bengal.
The CIN (Corporate Identification Number) of Jibok Pharmaceuticals is U24232WB2007PTC119509. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Jibok Pharmaceuticals was incorporated on 12 October 2007, making it 19+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Jibok Pharmaceuticals by revenue are Indo Fusion Interiors Private Limited, Azeudus Pharmaceuticals Private Limited, Assurmed Pharmacy Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (retail trading).
Biplab Raychaudhuri ceased to be Director on 11 Aug 2012. Pradip Kumar Ghosh was appointed as Director on 12 Oct 2007. Rajesh Kumar Sah was appointed as Director on 12 Oct 2007. Jibok Pharmaceuticals has 5 board changes on record in total.
Yes, Jibok Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-WB-14-0011670).
Jibok Pharmaceuticals can be reached through the website jibokpharmaceuticals.com. Its registered office is in Kolkata, West Bengal, India.
The registered office of Jibok Pharmaceuticals is at 2654 Barasat Road P.O – Nona – Chandanpukur P.S. Titagarh Muncipality – Barrackpore, Kolkata, West Bengal, India – 700122.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages